Latest Earnings News

Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.

L1 Global Long Short Fund (ASX:GLS) reported a striking $121.3 million net profit for FY26 following its strategic reset, declaring a fully franked 2.00 cent final dividend and targeting 8.00 cents per share for FY27.

MotorCycle Holdings Limited (ASX:MTO) posted a 21.3% revenue increase and 34% net profit growth for FY26, driven by organic sales and acquisitions. The company declared a higher final dividend and released its inaugural climate-related financial disclosures.

Taiton Resources has secured a farm-in agreement over EL 6468, significantly enlarging its Challenger West gold-copper project in South Australia. Historic drilling highlights shallow, high-grade mineralisation, while new soil sampling aims to sharpen upcoming drill targets.

The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.

Mastermyne Group Limited (ASX:MYE) delivered a robust FY26 with revenue up 13% to $237.7 million and underlying profit before tax surging 148% to $15.7 million, supported by contract wins and a record order book.

COG Financial Services lifted revenue 10% to $403.4 million and net profit after tax attributable to members by 29% to $24.24 million for FY26, driven by a 51% jump in its Salary Packaging segment including the Easifleet acquisition. The company declared a fully franked 7.0 cents per share dividend, suspending its dividend reinvestment plan.

Hiremii Limited posted an 8.6% revenue increase to $32.4 million and halved its net loss in FY26, reaching adjusted EBITDA breakeven as it prepares to rebrand as AQYR Limited.

Epiminder Limited reported a $42.7 million loss for FY26, driven by clinical trial and product development costs following a $125 million IPO. The company progresses its FDA-approved Minder implantable EEG monitor with a pivotal US trial and next-gen device on track for 2028 launch.

Tabcorp Holdings posted modest revenue growth and a sharp rise in net profit for FY26, while unveiling a major acquisition to accelerate its wagering technology transformation.

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

Netwealth Group posted record FY26 revenue of $391 million, up 21%, with adjusted net profit rising 16.2% to $135.4 million after excluding $105 million in First Guardian compensation. The company declared a fully franked 21-cent final dividend, maintaining a 9.1% increase in total dividends.